Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Plaque Psoriasis
Public ClinicalTrials.gov record NCT03343639. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Pruritus in Adults With Plaque Psoriasis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Study of the efficacy, safety, and tolerability of serlopitant for the treatment of pruritus in adults with plaque psoriasis
Study identification
- NCT ID
- NCT03343639
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 204 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 1, 2017 (Actual)
- Primary completion
- Oct 23, 2018 (Actual)
- Completion
- Nov 12, 2018 (Actual)
- Last update posted
- May 20, 2021
2017 – 2018
United States locations
- U.S. sites
- 39
- U.S. states
- 18
- U.S. cities
- 35
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Study Site 221 | Bryant | Arkansas | 72022 | — |
| Study Site 220 | Beverly Hills | California | 90212 | — |
| Study Site 204 | Fremont | California | 94538 | — |
| Study Site 356 | San Diego | California | 92108 | — |
| Study Site 202 | San Diego | California | 92123 | — |
| Study Site 215 | San Diego | California | 92123 | — |
| Study Site 376 | Santa Monica | California | 90404 | — |
| Study Site 212 | Clearwater | Florida | 33761 | — |
| Study Site 210 | Coral Gables | Florida | 33134 | — |
| Study Site 331 | Miami | Florida | 33144 | — |
| Study Site 348 | Miami | Florida | 33165 | — |
| Study Site 222 | North Miami Beach | Florida | 33162 | — |
| Study Site 206 | Sanford | Florida | 32771 | — |
| Study Site 213 | Boise | Idaho | 83704 | — |
| Study Site 360 | New Albany | Indiana | 47150 | — |
| Study Site 207 | South Bend | Indiana | 46617 | — |
| Study Site 228 | Louisville | Kentucky | 40202 | — |
| Study Site 216 | Louisville | Kentucky | 40241 | — |
| Study Site 506 | Ann Arbor | Michigan | 48103 | — |
| Study Site 219 | Clinton Township | Michigan | 48038 | — |
| Study Site 209 | Fridley | Minnesota | 55432 | — |
| Study Site 371 | Saint Joseph | Missouri | 64506 | — |
| Study Site 227 | Omaha | Nebraska | 68144 | — |
| Study Site 201 | East Windsor | New Jersey | 08520 | — |
| Study Site 375 | Forest Hills | New York | 11375 | — |
| Study Site 500 | New York | New York | 10023 | — |
| Study Site 516 | Bexley | Ohio | 43209 | — |
| Study Site 211 | Broomall | Pennsylvania | 19008 | — |
| Study Site 345 | Johnston | Rhode Island | 02919 | — |
| Study Site 205 | Murfreesboro | Tennessee | 37130 | — |
| Study Site 182 | College Station | Texas | 77845 | — |
| Study Site 224 | Houston | Texas | 77004 | — |
| Study Site 359 | Pflugerville | Texas | 78660 | — |
| Study Site 339 | Plano | Texas | 75024 | — |
| Study Site 203 | San Antonio | Texas | 78218 | — |
| Study Site 223 | Sugar Land | Texas | 77479 | — |
| Study Site 226 | Webster | Texas | 77598 | — |
| Study Site 217 | Norfolk | Virginia | 23502 | — |
| Study Site 336 | Richmond | Virginia | 23220 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03343639, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 20, 2021 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03343639 live on ClinicalTrials.gov.